Search results
Department of Health - Abu Dhabi Partners with Pfizer to Advance Research in Sickle Cell Disease and...
The Pilot News· 6 days agoThe Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate,...
Pfizer Is Getting Healthier and There's a Key Level for Buyers to Watch
TheStreet.com· 5 days agoIn the updated daily bar chart of PFE, below, I can see this is the second test of the 200-day...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga· 5 days agoOn Friday, Pfizer Inc PFE revealed its drug for an advanced form of lung cancer showed promising...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 2 days agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for...
2 High-Yield Dividend Stocks to Buy Right Now
The Motley Fool via AOL· 4 days agoImage source: Getty Images. Which high-yielders stand out as attractive buys heading into this event? Healthcare titans AbbVie (NYSE: ABBV) and Pfizer...
2 Dividend Stocks Billionaires Are Buying: Should You? | The Motley Fool
The Motley Fool· 2 days agoMany billionaires are active on Wall Street and largely built their wealth that way. Of course,...
Potential Price Increase for Pfizer Inc.
Knox Daily· 7 days agoPfizer Inc.’s filing revealed that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share,3,000 ...
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in...
Morningstar· 4 days agoTherapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, ...
Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment
Morningstar· 4 days agoRelay Therapeutics will collaborate with Pfizer to study atirmociclib in combination with RLY-2608 and fulvestrant in patients with certain types of metastatic breast cancer ...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 2 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...